Vidwan-ID : 132432



  • Dr Raj Kumar Koiri

  • Assistant Professor
  • Dr. Harisingh Gour Vishwavidyalaya, Sagar
Publications 2007 - 2022

Publications

  • 30
    Journal Articles
  • 1
    Book Chapter
  • 5
    Review
  • 1
    Editorial
  • 4
    Projects
  • 2
  • 1
  • 18

Citations / H-Index

394 Citations
12 h-index
483 Citations

Google Scholar

Co-author Network


Expertise

Zoology

(1) Cancer Biology and Therapeutics (2) Toxicology

Personal Information

Dr Raj Kumar Koiri

Male
Department of Zoology Dr Harisingh Gour Vishwavidyalaya
Sagar, Madhya Pradesh, India - 470003


Experience

  • Assistant Professor

    Department of Zoology

    Dr. Harisingh Gour Vishwavidyalaya, Sagar

  • Research Associate

    Banaras Hindu University


Qualification

  • Ph.D.

    Banaras Hindu University


Honours and Awards

2021

Outstanding Contribution in Reviewing

The Editors of Journal of Biochemical and Molecular Toxicology, Wiley

2021

Outstanding Scientist Award

International Scientist Awards on Engineering, Science and Medicine by VDGOOD Professional Association, Mysore, India

2017

Outstanding Contribution in Reviewing

The Editors of Food and Chemical Toxicology, Elsevier, Amsterdam, The Netharlands

Read More
2021

Outstanding Contribution in Reviewing

The Editors of Journal of Biochemical and Molecular Toxicology, Wiley

2021

Outstanding Scientist Award

International Scientist Awards on Engineering, Science and Medicine by VDGOOD Professional Association, Mysore, India

2017

Outstanding Contribution in Reviewing

The Editors of Food and Chemical Toxicology, Elsevier, Amsterdam, The Netharlands

2017

Outstanding Contribution in Reviewing

The Editors of Journal of Hazardous Materials, Elsevier, Amsterdam, The Netharlands

2015

DST-SERB Young Scientist

DST-SERB

2010

Best Poster Award

Society of Free Radical Research – India

Read Less

Doctoral Theses Guided

2020

Studies on metabocentric adaptation and transformations for survival occurring in hepatocellular carcinoma

Divya Rawat, Dr. Harisingh Gour Vishwavidyalaya, Sagar

2019

Biochemical Studies to Investigate the Effect of Phosphodiesterase-5 inhibitor on Aflatoxin B1 Induced Hepatocellular Carcinoma

Saurabh Kumar Chhonker, Dr. Harisingh Gour Vishwavidyalaya, Sagar

2020

Studies on metabocentric adaptation and transformations for survival occurring in hepatocellular carcinoma

Divya Rawat, Dr. Harisingh Gour Vishwavidyalaya, Sagar

2019

Biochemical Studies to Investigate the Effect of Phosphodiesterase-5 inhibitor on Aflatoxin B1 Induced Hepatocellular Carcinoma

Saurabh Kumar Chhonker, Dr. Harisingh Gour Vishwavidyalaya, Sagar

Read Less

Membership In Professional Bodies

2008

Indian Society of Cell Biology, India

Life member (Membership No. 2008010)

2008

Indian Society of Cell Biology, India

Life member (Membership No. 2008010)

Read Less

Membership In Committees

2023

Research Advisory Committee (Mahatma Gandhi Central University)

Subject expert nominated by the Vice-Chancellor

2018

• Members of the Academic Council, National Resource Center of Zoology, Dr. Harisingh Gour Vishwavidyalaya, Sagar

Member

2023

Research Advisory Committee (Mahatma Gandhi Central University)

Subject expert nominated by the Vice-Chancellor

2018

• Members of the Academic Council, National Resource Center of Zoology, Dr. Harisingh Gour Vishwavidyalaya, Sagar

Member

Read Less

Research Projects

DBT Builder-Level II

Funding Agency : Department of Biotechnology

Implication of unfolded protein response (UPR) – Sirtuin 1 (SIRT 1) – HIF-2α - p53 – ephrin regulatory loop and its modulation by phosphodiesterase inhibitors in hepatocellular carcinoma

Funding Agency : SERB

Targeting phosphodiesterase to enhance drug delivery and overcome drug resistance at tumor site in hepatocellular carcinoma (HCC)

Funding Agency : SERB

Read More

DBT Builder-Level II

Funding Agency : Department of Biotechnology

Implication of unfolded protein response (UPR) – Sirtuin 1 (SIRT 1) – HIF-2α - p53 – ephrin regulatory loop and its modulation by phosphodiesterase inhibitors in hepatocellular carcinoma

Funding Agency : SERB

Targeting phosphodiesterase to enhance drug delivery and overcome drug resistance at tumor site in hepatocellular carcinoma (HCC)

Funding Agency : SERB

Molecular characterization of the cross-talk between SIRT-1 pathway and biochemical targets downstream to HIF-PI3K/AKT pathway in hepatocellular carcinoma (HCC)

Funding Agency : UGC

Read Less